MetaCap

Cabaletta Bio (CABA) News

NASDAQ: CABAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.9361-0.0739 (-7.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CABA news summary

We found 6 recent headlines mentioning Cabaletta Bio (CABA): 0 in the past week and 6 in the past 30 days, most often from Nasdaq, GlobeNewswire. CABA is making an outsized move today, down 7.32% at $0.9361, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Cabaletta Bio Presents New Rese-cel Phase 1/2 Clinical Data at ACR Convergence 2026", was published by Nasdaq on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Cabaletta Bio headlines

Stocks mentioned alongside CABA

Compare CABA